Home monitoring in interstitial lung diseases

Marlies S Wijsenbeek*, Catharina C Moor, Kerri A Johannson, Peter D Jackson, Yet H Khor, Yasuhiro Kondoh, Sujeet K Rajan, Gabriela C Tabaj, Brenda E Varela, Pieter van der Wal, Richard N van Zyl-Smit, Michael Kreuter, Toby M Maher

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)

Abstract

The widespread use of smartphones and the internet has enabled self-monitoring and more hybrid-care models. The COVID-19 pandemic has further accelerated remote monitoring, including in the heterogenous and often vulnerable group of patients with interstitial lung diseases (ILDs). Home monitoring in ILD has the potential to improve access to specialist care, reduce the burden on health-care systems, improve quality of life for patients, identify acute and chronic disease worsening, guide treatment decisions, and simplify clinical trials. Home spirometry has been used in ILD for several years and studies with other devices (such as pulse oximeters, activity trackers, and cough monitors) have emerged. At the same time, challenges have surfaced, including technical, analytical, and implementational issues. In this Series paper, we provide an overview of experiences with home monitoring in ILD, address the challenges and limitations for both care and research, and provide future perspectives.

Original languageEnglish
Pages (from-to)97-110
Number of pages14
JournalThe Lancet Respiratory Medicine
Volume11
Issue number1
Early online date4 Oct 2022
DOIs
Publication statusPublished - Jan 2023

Bibliographical note

Publisher Copyright: © 2023 Elsevier Ltd

Fingerprint

Dive into the research topics of 'Home monitoring in interstitial lung diseases'. Together they form a unique fingerprint.

Cite this